.webp "APPLE DEFEATS BID TO REINSTATE WATCH IMPORT BAN IN MAJOR LEGAL WIN")
WASHINGTON— In a decisive turn for the consumer electronics giant, a U.S. trade tribunal has ruled in favor of Apple Inc., rejecting a bid by medical technology firm Masimo to reinstate an import ban on its flagship smartwatches. The U.S. International Trade Commission (ITC) officially closed the case on Friday, April 17, 2026, after declining to review an earlier judicial finding that Apple’s redesigned hardware does not infringe on Masimo’s patents.
The ruling provides immediate relief for Apple’s Series 9, Ultra 2, and newer models, which have been at the center of a high-stakes intellectual property battle over pulse oximetry (blood-oxygen monitoring) technology.
A Technical Workaround Validated
The conflict reached a boiling point in December 2023 when the ITC initially banned the import of Apple Watches that utilized Masimo’s patented light-based sensors. To circumvent the restriction, Apple implemented a software-driven redesign:
The "iPhone Link" Solution: Unlike the original version, which processed and displayed oxygen levels directly on the watch face, the redesigned watches now perform the data analysis on a linked iPhone.
User Experience: Results are exclusively viewable within the Health app on the iPhone, a move Apple’s engineers successfully argued separates its tech from Masimo’s "on-device" patent claims.
Customs Approval: This approach was previously greenlit by U.S. Customs and Border Protection last August, a decision the ITC has now effectively upheld by refusing further review.
Persistent Legal Overhang
While the ITC victory prevents a shutdown of U.S. sales, Apple’s legal challenges regarding its health-monitoring features remain complex.
The $634 Million Verdict: In November 2025, a federal jury in California ordered Apple to pay $634 million in damages for separate patent infringements related to heart rate notifications and workout modes. Apple is currently appealing this verdict.
Trade Secret Theft: Masimo continues to pursue claims in civil court alleging that Apple "poached" its key medical staff to acquire proprietary sensor technology.
Appellate Risk: Masimo, now owned by Danaher, has signaled its intent to appeal the latest ITC decision to the U.S. Court of Appeals for the Federal Circuit.
Strategic Outlook: The Future of Wearables
For Apple, the ability to continue shipping watches with functional, albeit modified, health sensors is critical. The Apple Watch remains a cornerstone of its $40 billion Wearables, Home, and Accessories segment.
| Event | Status |
| ITC Import Ban Bid | Defeated (April 2026) |
| California Jury Verdict | $634M Penalty (Under Appeal) |
| Blood-Oxygen Status | Functional via iPhone Health App |
| Future Hardware | Series 11+ rumored to use "non-infringing" sensor sets |
In a statement, Apple thanked the commission, asserting that the decision ensures it can "continue to offer this important health feature" to millions of users, while dismissing Masimo’s legal campaign as a targeted effort to disrupt a superior competitor.
#Apple #Masimo #AppleWatch #TechLaw #IntellectualProperty #HealthTech #X
.webp)